← Open Payments lookup

RACHEL MILLER: Open Payments

NPI 1013956291 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,299 in 193 payments from 21 companies in 2025. Trend: 2023 $4,524 · 2024 $4,133 · 2025 $3,299

Food & beverage: $3,129Education: $170
CompanyPaymentsAmount
ABBVIE INC.40$696
Janssen Biotech, Inc.35$546
UCB, Inc.11$324
GENZYME CORPORATION12$232
Novartis Pharmaceuticals Corporation13$218
Lilly USA, LLC8$209
SUN PHARMACEUTICAL INDUSTRIES INC.8$180
Galderma Laboratories, L.P.20$166
Regeneron Healthcare Solutions, Inc.10$141
Incyte Corporation6$108

Products named: TREMFYA, RINVOQ, DUPIXENT, Bimzelx, SKYRIZI, TALTZ, NEMLUVIO, OPZELURA.

Industry payments across TX — which companies pay providers there.